Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49

United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

14 insiders · 133 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Troy Edward Wilson

President and CEO

$3.06M (5)

$18.91M (20) scheduled

−$15.84M

2,534,667

2.85%

$27.24M

−26.9%

EcoR1 Capital Fund Qualified, L.P. entity

10% owner

$5.08M (8)

$350.06K (1)

+$4.73M

4,408,097

4.96%

$47.38M

+8.6%

Mollie Leoni

Chief Medical Officer

—

$1.67M (13) scheduled

−$1.67M

141,095

0.1586%

$1.52M

+200.4%

Kathleen Ford

Chief Operating Officer

—

$1.55M (17) scheduled

−$1.55M

142,986

0.1607%

$1.54M

+34.0%

Marc Grasso

CFO, Cbo

—

$980.00K (4) scheduled

−$980.00K

21,900

0.0246%

$235.40K

+655.7%

Teresa Brophy Bair

Chief Legal Officer

—

$972.46K (14) scheduled

−$972.46K

187,002

0.2102%

$2.01M

+1,736%

Brian T. Powl

Chief Commercial Officer

—

$755.38K (11)

−$755.38K

136,819

0.1538%

$1.47M

+20,080%

Thomas Malley

Director

$575.00K (1)

—

+$575.00K

149,557

0.1681%

$1.61M

+67.0%

Francis Burrows

Chief Scientific Officer

—

$484.59K (5) scheduled

−$484.59K

42,327

0.0476%

$454.96K

+67.6%

Antonio Gualberto

Head of Development & CMO

—

$379.90K (1) scheduled

−$379.90K

339,973

0.3822%

$3.65M

0.0%

Stephen Dale

Chief Medical Officer

—

$359.43K (5)

−$359.43K

38,817

0.0436%

$417.23K

—

Thomas James Doyle

SVP, Finance & Accounting

—

$301.85K (17)

−$301.85K

142,928

0.1607%

$1.54M

+667.4%

Faheem Hasnain

Director

—

$291.22K (2) scheduled

−$291.22K

23,983

0.0270%

$257.79K

0.0%

Kirsten Flowers

CCO & Chief Strategy Officer

—

$26.47K (1)

−$26.47K

20,605

0.0232%

$221.48K

+3,272%